The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses
View ORCID ProfileAlejandra Castanon, View ORCID ProfileRebolj M Matejka, View ORCID ProfileFrancesca Pesola, View ORCID ProfilePeter Sasieni
doi: https://doi.org/10.1101/2020.11.30.20240754
Alejandra Castanon
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Rebolj M Matejka
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Francesca Pesola
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Peter Sasieni
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences

Data Availability
source data for this study is freely available in published literature.
Posted November 30, 2020.
The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses
Alejandra Castanon, Rebolj M Matejka, Francesca Pesola, Peter Sasieni
medRxiv 2020.11.30.20240754; doi: https://doi.org/10.1101/2020.11.30.20240754
Subject Area
Subject Areas
- Addiction Medicine (76)
- Allergy and Immunology (196)
- Anesthesia (54)
- Cardiovascular Medicine (489)
- Dermatology (56)
- Emergency Medicine (168)
- Epidemiology (5689)
- Gastroenterology (216)
- Geriatric Medicine (88)
- Health Economics (232)
- Health Informatics (762)
- Health Policy (392)
- Hematology (105)
- HIV/AIDS (182)
- Medical Education (117)
- Medical Ethics (28)
- Nephrology (93)
- Neurology (850)
- Nursing (44)
- Nutrition (141)
- Oncology (514)
- Ophthalmology (163)
- Orthopedics (44)
- Otolaryngology (107)
- Pain Medicine (48)
- Palliative Medicine (21)
- Pathology (149)
- Pediatrics (250)
- Primary Care Research (114)
- Public and Global Health (2231)
- Radiology and Imaging (377)
- Respiratory Medicine (312)
- Rheumatology (109)
- Sports Medicine (82)
- Surgery (118)
- Toxicology (25)
- Transplantation (34)
- Urology (42)